In the 1990s, exendin-4, a GLP-1 receptor agonist (GLP-1 RA) structurally similar to endogenous GLP-1, was isolated from Gila monster venom, which subsequently led to the approval of exenatide for type 2 diabetes mellitus (T2DM) management in 2005 [2]
GLP-1 agonists as a class offer substantial benefits, including improved glycemic control, weight reduction, and cardiovascular protection, that millions of Americans have come to rely on, and semaglutide brands such as Ozempic and Wegovy have emerged as the drugs of choice for most patients
In rare cases, menstrual irregularities may occur
Supply could not keep pace with fervent demand for the drug, which reached such dizzying levels of popularity that it transformed Novo Nordisk into one of the worlds most valuable companies, with a market capitalization larger than the rest of the economy of its home nation of Denmark
Nationwide Delivery & Ongoing Clinical Support FuturHealth's infrastructure supports nationwide prescription delivery, which means you don't need to worry about finding a local clinic, pharmacy, or practitioner familiar with GLP-1 therapy
Serious adverse events (pancreatitis, gallbladder issues, hypoglycemia in diabetic patients) are documented in trials and apply to both forms